The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Bayer/Onyx; Novartis; Pfizer
 
Igor Stukalin
No Relationships to Disclose
 
Connor Wells
No Relationships to Disclose
 
Frede Donskov
Research Funding - GlaxoSmithKline; Novartis; Pfizer
 
Brian I. Rini
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Millennium (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Jae-Lyun Lee
Honoraria - Pfizer
Consulting or Advisory Role - Astellas Pharma
Research Funding - Pfizer
 
Georg A. Bjarnason
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer
 
Benoit Beuselinck
No Relationships to Disclose
 
Martin Smoragiewicz
No Relationships to Disclose
 
Ajjai Shivaram Alva
Honoraria - Eisai
Consulting or Advisory Role - Eisai
Research Funding - BIND Biosciences; Bristol-Myers Squibb; Genentech; Novartis; Oncogenex
 
Sandy Srinivas
Consulting or Advisory Role - Genentech/Roche; medivation; pfizer
Research Funding - GlaxoSmithKline
 
Lori Wood
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Janssen Oncology; Pfizer
 
James Brugarolas
No Relationships to Disclose
 
Sumanta Kumar Pal
Honoraria - Medivation; Novartis
Consulting or Advisory Role - Aveo; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Takeshi Yuasa
No Relationships to Disclose
 
Reuben James Broom
No Relationships to Disclose
 
Ravindran Kanesvaran
Consulting or Advisory Role - Bayer; GlaxoSmithKline
Speakers' Bureau - GlaxoSmithKline; Pfizer
 
Aristotelis Bamias
No Relationships to Disclose
 
Jennifer J. Knox
Consulting or Advisory Role - AVEO
Research Funding - Pfizer
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer